BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22261202)

  • 21. Diffusion-weighted MR imaging of the liver of hepatitis C patients.
    Boulanger Y; Amara M; Lepanto L; Beaudoin G; Nguyen BN; Allaire G; Poliquin M; Nicolet V
    NMR Biomed; 2003 May; 16(3):132-6. PubMed ID: 12884356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
    Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
    World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue Doppler imaging and tissue strain imaging for the evaluation of hepatic fibrosis in patients with chronic hepatitis B.
    Wang Y; Wu Z; Ju Y; Cao L; Shi L; Tong F; Jiang X; Zhu C
    Ultrasound Med Biol; 2013 Sep; 39(9):1527-35. PubMed ID: 23791352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?
    Besheer T; Razek AAKA; El Bendary M; Abd El Maksoud M; Elalfy H; Zalata K; Elkashef W; Zaghloul H; El Gilany AH
    Turk J Gastroenterol; 2017 Jul; 28(4):283-288. PubMed ID: 28594328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of diagnosing and staging liver fibrosis with diffusion weighted imaging.
    Zhu NY; Chen KM; Chai WM; Li WX; Du LJ
    Chin Med Sci J; 2008 Sep; 23(3):183-6. PubMed ID: 18853855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver Fibrosis Staging with MR Elastography: Comparison of Diagnostic Performance between Patients with Chronic Hepatitis B and Those with Other Etiologic Causes.
    Chang W; Lee JM; Yoon JH; Han JK; Choi BI; Yoon JH; Lee KB; Lee KW; Yi NJ; Suh KS
    Radiology; 2016 Jul; 280(1):88-97. PubMed ID: 26844364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in liver fibrosis between patients with chronic hepatitis B and C: evaluation by acoustic radiation force impulse measurements at 2 locations.
    Tai DI; Tsay PK; Jeng WJ; Weng CC; Huang SF; Huang CH; Lin SM; Chiu CT; Chen WT; Wan YL
    J Ultrasound Med; 2015 May; 34(5):813-21. PubMed ID: 25911714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis.
    Herrmann E; de Lédinghen V; Cassinotto C; Chu WC; Leung VY; Ferraioli G; Filice C; Castera L; Vilgrain V; Ronot M; Dumortier J; Guibal A; Pol S; Trebicka J; Jansen C; Strassburg C; Zheng R; Zheng J; Francque S; Vanwolleghem T; Vonghia L; Manesis EK; Zoumpoulis P; Sporea I; Thiele M; Krag A; Cohen-Bacrie C; Criton A; Gay J; Deffieux T; Friedrich-Rust M
    Hepatology; 2018 Jan; 67(1):260-272. PubMed ID: 28370257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease.
    Tokgöz Ö; Unal I; Turgut GG; Yildiz S
    Acta Clin Belg; 2014 Dec; 69(6):426-32. PubMed ID: 25103596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
    Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance-based total liver volume and magnetic resonance-diffusion weighted imaging for staging liver fibrosis in mini-pigs.
    Li H; Chen TW; Chen XL; Zhang XM; Li ZL; Zeng NL; Zhou L; Wang LY; Tang HJ; Li CP; Li L; Xie XY
    World J Gastroenterol; 2012 Dec; 18(48):7225-33. PubMed ID: 23326127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
    Lewin M; Poujol-Robert A; Boëlle PY; Wendum D; Lasnier E; Viallon M; Guéchot J; Hoeffel C; Arrivé L; Tubiana JM; Poupon R
    Hepatology; 2007 Sep; 46(3):658-65. PubMed ID: 17663420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B.
    Liu J; Ji Y; Ai H; Ning B; Zhao J; Zhang Y; Dun G
    Korean J Radiol; 2016; 17(3):396-404. PubMed ID: 27134527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
    Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
    J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Application of Parametric Micro-Flow Imaging in the Evaluation of Liver Fibrosis.
    Huang S; Liang P; Yu X; Wang Z; Cheng Z; Han Z; Yu J; Liu F; Zhang M; Zhang D
    Ultrasound Q; 2018 Sep; 34(3):148-155. PubMed ID: 30020267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C.
    Wu WP; Chou CT; Chen RC; Lee CW; Lee KW; Wu HK
    PLoS One; 2015; 10(10):e0140068. PubMed ID: 26469342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study.
    Kim SU; Kim YC; Choi JS; Kim KS; Choi GH; Choi JS; Park JY; Kim DY; Ahn SH; Choi EH; Park YN; Chon CY; Han KH; Kim MJ
    Magn Reson Imaging; 2010 Jul; 28(6):802-11. PubMed ID: 20395100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL; Xiao YQ; Chen F
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.